Abstract
Hypoxic / / ischemic (H / I)neuronal degeneration in the developing central nervous system (CNS)is mediated by an excitotoxic mechanism,and it has also been reported that an apoptosis mechanism is involved.However,there is much disagreement regarding how excitotoxic and apoptotic cell death processes relate to one another.Some authors believe that an excitotoxic stimulus directly triggers apoptotic cell death,but this interpretation is largely speculative at the present time.Our findings support the interpretation that excitotoxic and apoptotic neurodegeneration are two separate and distinct cell death processes that can be distinguished from one another by ultrastructural evaluation.Here we review evidence supporting this interpretation,including evidence that H / I in the developing CNS triggers two separate waves of neurodegeneration,the first being excitotoxic and the second being apoptotic.The first (excitotoxic)wave destroys neurons that would normally provide synaptic inputs or synaptic targets for the neurons that die in the second (apoptotic)wave.Since neurons,during the developmental period of synaptogenesis,are programmed to commit suicide if they fail to achieve normal connectivity,this explains why neuroapoptosis occurs following H / I in the developing CNS.However,it does not support the interpretation that H / I directly triggers apoptotic neurodegeneration.Rather,it documents that H / I directly triggers excitotoxic neurodegeneration,and apoptotic neurodegeneration ensues subsequently as the natural response of developing neurons to a specific kind of deprivation -loss of the ability to form normal synaptic connections.
Keywords: Neuronal Cell, synaptogenesis
Current Molecular Medicine
Title: Excitotoxic Versus Apoptotic Mechanisms of Neuronal Cell Death in Perinatal Hypoxia / Ischemia
Volume: 4 Issue: 2
Author(s): Chainllie Young, Tatyana Tenkova, Krikor Dikranian and John W. Olney
Affiliation:
Keywords: Neuronal Cell, synaptogenesis
Abstract: Hypoxic / / ischemic (H / I)neuronal degeneration in the developing central nervous system (CNS)is mediated by an excitotoxic mechanism,and it has also been reported that an apoptosis mechanism is involved.However,there is much disagreement regarding how excitotoxic and apoptotic cell death processes relate to one another.Some authors believe that an excitotoxic stimulus directly triggers apoptotic cell death,but this interpretation is largely speculative at the present time.Our findings support the interpretation that excitotoxic and apoptotic neurodegeneration are two separate and distinct cell death processes that can be distinguished from one another by ultrastructural evaluation.Here we review evidence supporting this interpretation,including evidence that H / I in the developing CNS triggers two separate waves of neurodegeneration,the first being excitotoxic and the second being apoptotic.The first (excitotoxic)wave destroys neurons that would normally provide synaptic inputs or synaptic targets for the neurons that die in the second (apoptotic)wave.Since neurons,during the developmental period of synaptogenesis,are programmed to commit suicide if they fail to achieve normal connectivity,this explains why neuroapoptosis occurs following H / I in the developing CNS.However,it does not support the interpretation that H / I directly triggers apoptotic neurodegeneration.Rather,it documents that H / I directly triggers excitotoxic neurodegeneration,and apoptotic neurodegeneration ensues subsequently as the natural response of developing neurons to a specific kind of deprivation -loss of the ability to form normal synaptic connections.
Export Options
About this article
Cite this article as:
Young Chainllie, Tenkova Tatyana, Dikranian Krikor and Olney W. John, Excitotoxic Versus Apoptotic Mechanisms of Neuronal Cell Death in Perinatal Hypoxia / Ischemia, Current Molecular Medicine 2004; 4 (2) . https://dx.doi.org/10.2174/1566524043479158
DOI https://dx.doi.org/10.2174/1566524043479158 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
Current Pharmaceutical Design Alzheimer’s Disease: Erythrocyte 2,3-diphosphoglycerate Content and Circulating Erythropoietin
Current Alzheimer Research Pharmacological Targeting of the Inflamed Intestinal Barrier
Current Pharmaceutical Design Somatostatin Replacement: A New Strategy for Treating Diabetic Retinopathy
Current Medicinal Chemistry The Updated Role of Oxidative Stress in Subarachnoid Hemorrhage
Current Drug Delivery Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Potential Roles of HDAC Inhibitors in Mitigating Ischemia-induced Brain Damage and Facilitating Endogenous Regeneration and Recovery
Current Pharmaceutical Design Pharmacological Manipulation of Brain Glycogenolysis as a Therapeutic Approach to Cerebral Ischemia
Mini-Reviews in Medicinal Chemistry Polyphenol Supplementation as a Complementary Medicinal Approach to Treating Inflammatory Bowel Disease
Current Medicinal Chemistry Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Current Respiratory Medicine Reviews Are the Myokines the Mediators of Physical Activity-Induced Health Benefits?
Current Pharmaceutical Design Development of Insulin Resistance During Aging: Involvement of Central Processes and Role of Adipokines
Current Protein & Peptide Science Anti-Angiogenic Effects of Resveratrol on Cerebral Angiogenesis
Current Neurovascular Research Interrelationships Between Cyclooxygenases and Aromatase: Unraveling the Relevance of Cyclooxygenase Inhibitors in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry The Impact of Oxidative Stress on Islet Transplantation and Monitoring the Graft Survival by Non-Invasive Imaging
Current Medicinal Chemistry Targeting Cancer Stem Cells with Natural Products
Current Drug Targets In Vivo MR Imaging of the Flow of the Brain Interstitial Fluid
Neuroscience and Biomedical Engineering (Discontinued) Src Kinase Inhibitors: An Update on Patented Compounds
Current Medicinal Chemistry Metabotropic Glutamate Receptors and Interacting Proteins in Epileptogenesis
Current Neuropharmacology The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design